1997
DOI: 10.1126/science.277.5332.1602
|View full text |Cite
|
Sign up to set email alerts
|

Blunting Nature's Swiss Army Knife

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
32
0

Year Published

2001
2001
2015
2015

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 44 publications
(32 citation statements)
references
References 0 publications
0
32
0
Order By: Relevance
“…Protease inhibitors are under investigation for numerous and varied pathologies (Siefe, 1997). Both of these classes of compounds can have anti-inflammatory actions and are existing examples of crossover between neuronal and vesicant pathology associated with nerve and blister agents, respectively (Siefe, 1997;Dery et al, 1998;Bal-Price and Brown, 2001;Mabely et al, 2001).…”
Section: Protease and Parp Inhibitorsmentioning
confidence: 99%
“…Protease inhibitors are under investigation for numerous and varied pathologies (Siefe, 1997). Both of these classes of compounds can have anti-inflammatory actions and are existing examples of crossover between neuronal and vesicant pathology associated with nerve and blister agents, respectively (Siefe, 1997;Dery et al, 1998;Bal-Price and Brown, 2001;Mabely et al, 2001).…”
Section: Protease and Parp Inhibitorsmentioning
confidence: 99%
“…Disproportion in the ratios of proteinases to inhibitors caused by genetic defects, inflammation or certain harmful impacts may lead to severe pathological effects [1]. Thus, proteinases and their specific inhibitors represent worthwhile targets for the development of drugs [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Drugs reported to inhibit cutaneous histopathology in HD-exposed rodents include niacinamide, 21 Protease inhibitors and soluble immune receptors for complement components, cytokines and soluble FcR to reduce pathology in conditions as varied as cancer, rheumatoid arthritis and infectious diseases are two major areas of drug discovery. [24][25][26] Serine and cysteine protease inhibitors can inhibit HD-increased proteolysis in human peripheral blood lymphocytes 6 and prevent the epidermal-dermal separation in human skin explants 24 h after HD exposure. 27 Matrix metalloproteinase inhibitors can greatly reduce neutrophil infiltration and alkali-induced corneal lesions, and show inflammatory and proteolytic mechanisms similar to those proposed for HD.…”
Section: Discussionmentioning
confidence: 99%